The VA seeks a national, enterprise‑wide IDIQ contract (or multiple single‑award IDIQs) to supply FDA‑cleared electro‑therapeutic devices and associated consumables for non‑opioid pain management across all VA medical facilities. The procurement covers portable TENS units, IFC devices, short‑wave diathermy (thermal and non‑thermal) systems, and portable neuromodulation devices for headache disorders, together with required electrode kits, chargers, and accessories. Offers must include full technical capability statements, FDA 510(k) clearance letters, product samples shipped to the VA Denver Logistics Service, and a complete set of mandatory certifications (Buy‑American or Trade‑Agreements, subcontracting limitations, past‑performance). Evaluation will be tiered (SDVOSB → VOSB → other small business → large business) and use LPTA for most CLINs and Best‑Value for the neuromodulation line item.
• Scope: Supply of FDA‑cleared TENS, IFC, short‑wave diathermy, and neuromodulation devices plus electrode packs, chargers, and related accessories.
• Quantity: Estimated total of ~942,430 TENS devices and ~5.26 million electrode packs over five years (plus additional IFC, diathermy, and neuromodulation units).
• Requirements: New OEM products, 30‑day delivery after order, 1‑year warranty, electronic invoicing (Tungsten), EDI capability, and strict Buy‑American/TAA compliance.
• Evaluation: LPTA for CLIN X001‑X004; Best‑Value (technical 60 % + past performance 15 % + price 25 %) for CLIN X005; tiered set‑aside favors SDVOSBs and VOSBs.
• Timeline: Questions due Oct 5 2026; proposal & sample submission due Oct 19 2026; anticipated award by Jan 19 2027; contract period Jan 2027 – Jan 2032.